Yuhan (XKRX:000100) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:000100 Yuhan Corp XKRX:000100
78 GF Score
Price ₩83,700.00
GF Value ₩113,769.34
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Yuhan Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XKRX:000100 vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Yuhan's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yuhan Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yuhan's Short Interest distribution charts can be found below:

* The bar in red indicates where Yuhan's Short Interest falls into.


XKRX:000100
78GF Score
Yuhan Corp XKRX:000100
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Yuhan (XKRX:000100) Overvalued in 2026?

Based on GuruFocus' analysis, Yuhan stock appears to be undervalued. The current stock price of ₩83,700.00 is trading 26.4% below its estimated GF Value™ of ₩113,769.34. GuruFocus considers Yuhan to be Modestly Undervalued.

Key valuation signals for XKRX:000100:

  • Short Interest:
  • GF Value™: ₩113,769.34 vs. price of ₩83,700.00 (26.4% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the XKRX:000100 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Yuhan Business Description

Other Exchanges 000105:Korea
Address 74 Noryangjin-ro, Daebang-dong, Dongjak-gu, Seoul, KOR
Yuhan Corp is a pharmaceutical company. The core business of the company is classified as primary and specialty care, dietary supplements, household and animal care, and contract manufacturing of active pharmaceutical ingredients. The company offers one-stop custom synthesis services from research and development to commercial production of active pharmaceutical products (APIs) and intermediates for the following disease treatments: antivirals (HCV and HIV), antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds for international markets.
78GF Score

Get the complete analysis for XKRX:000100

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩83,700.00
Price
₩113,769.34
GF Value